Novel Agents Versus Conventional Drugs for the Treatment of Relapsed Multiple Myeloma Patients: Experience of a Single Center over the Last 25 Years

被引：0
|
作者：
Grammatico, Sara [1 ]
Lisi, Elisabetta [1 ]
Cesini, Laura [1 ]
Vallone, Maria Letizia [1 ]
Capria, Saveria [1 ]
Foa, Robin [1 ]
Petrucci, Maria Teresa [1 ]
机构：
[1] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Hematol, Rome, Italy
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] IXAZOMIB, LENALIDOMIDE, AND DEXAMETHASONE FOR RELAPSED MULTIPLE MYELOMA: AN EARLY SINGLE CENTER EXPERIENCE IN RUSSIA
    Luchinin, A.
    Semochkin, S.
    Minaeva, N.
    Samarina, S.
    HAEMATOLOGICA, 2018, 103 : 40 - 40
  • [42] RENAL IMPAIRMENT IN PATIENTS WITH MULTIPLE MYELOMA : A SINGLE CENTER EXPERIENCE
    El Meknassi, Imen
    Guedri, Yosra
    Azzabi, Awatef
    Mrabet, Sanda
    Fradi, Asma
    Sahtout, Wissal
    Ben Aicha, Narjes
    Zellama, Dorsaf
    Achour, Abdellatif
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [43] Renal failure in patients with multiple myeloma: a single center experience
    Al-Mueilo, Samir H.
    Al-Amri, Ali M.
    SAUDI MEDICAL JOURNAL, 2008, 29 (03) : 466 - 468
  • [44] Improvements in Patient Outcomes with Autologous Stem Cell Transplantation for Multiple Myeloma over 25 Years at a Single Center
    Wong, Sandy W.
    Warner, Melissa
    Moreno-Koehler, Alejandro
    Kritharis, Athena
    Coyle, Michael E.
    Black, Deborah
    Relias, Valerie
    Fogaren, Terry
    Lyons, Nancy Cody
    Toka, Francois
    Larivee, Denise
    Smith, Hedy
    Evens, Andrew M.
    Kao, Grace
    Sprague, Kellie
    Klein, Andreas K.
    Miller, Kenneth B.
    Comenzo, Raymond L.
    BLOOD, 2015, 126 (23)
  • [45] COMPARATIVE REAL WORLD EFFECTIVENESS OF NOVEL AGENTS VERSUS CONVENTIONAL THERAPIES IN MULTIPLE MYELOMA PATIENTS IN SWEDEN
    Thilakarathne, P.
    Diels, J.
    van Sanden, S.
    Liwing, J.
    Van Agthoven, M.
    Chirita, O.
    Nahi, H.
    VALUE IN HEALTH, 2014, 17 (07) : A545 - A546
  • [46] Outcome of COVID-19 infection in 50 multiple myeloma patients treated with novel drugs: single-center experience
    Krejci, Marta
    Pour, Ludek
    Adam, Zdenek
    Sandecka, Viera
    Stork, Martin
    Sevcikova, Sabina
    Krejci, Martin
    Knechtova, Zdenka
    Kral, Zdenek
    ANNALS OF HEMATOLOGY, 2021, 100 (10) : 2541 - 2546
  • [47] Outcome of COVID-19 infection in 50 multiple myeloma patients treated with novel drugs: single-center experience
    Marta Krejci
    Ludek Pour
    Zdenek Adam
    Viera Sandecka
    Martin Stork
    Sabina Sevcikova
    Martin Krejci
    Zdenka Knechtova
    Zdenek Kral
    Annals of Hematology, 2021, 100 : 2541 - 2546
  • [48] Advances in the Treatment of Relapsed and Refractory Multiple Myeloma in Patients with Renal Insufficiency: Novel Agents, Immunotherapies and Beyond
    Bozic, Boris
    Rutner, Jens
    Zheng, Chang
    Ruckser, Reinhard
    Selimi, Flonza
    Racz, Krysztina
    Koecher, Martin
    Tatzreiter, Georg
    Sebesta, Christian
    CANCERS, 2021, 13 (20)
  • [49] Clinical Outcomes in Relapsed/Refractory Multiple Myeloma Patients Receiving Sequential Elotuzumab and Daratumumab: A Single Center Experience
    Basher, Fahmin
    Paul, Yonette
    Hoffman, James E.
    BLOOD, 2020, 136
  • [50] AUTOLOGOUS STEM CELL TRANSPLANT IN MULTIPLE MYELOMA IN THE ERA OF CONVENTIONAL CHEMOTHERAPY AND NOVEL DRUGS - A SINGLE CENTRE EXPERIENCE
    Minarik, J.
    Faber, E.
    Raida, L.
    Szotkowski, T.
    Skoumalova, I
    Pika, T.
    Krhovska, P.
    Bacovsky, J.
    Zapletalova, J.
    Scudla, V
    Papajik, T.
    HAEMATOLOGICA, 2018, 103 : 28 - 29
12345